Shreeram Agharkar is Director at RELMADA THERAPEUTICS, INC. (RLMD). They have made 2 open-market trades across 1 company since 2015, most recently 2015-12-31.
CIK 0001630639
2 open-market purchases totalling $5K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RLMD | 5,759 | $18K |
Shares reported on the most recent Form 4, priced at the 2016-01-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.